Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 08/26 10:02:28 pm
93.26 USD   -0.55%
08/26 CVS HEALTH : Fighting Opioid Abuse with Technology
08/26 CVS HEALTH : Talent Is Ageless
08/24 CVS HEALTH : and Easterseals Celebrate Ten Years of Partnership to S..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

CVS Caremark 4th-Quarter Profit Rose 2.6% Amid Continued Sales Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/06/2013 | 01:52pm CEST
   By Tess Stynes 
 

CVS Caremark Corp.'s (>> CVS Caremark Corporation) fourth-quarter earnings rose 2.6% as the company reported revenue growth in its pharmacy-services and retail drugstore operations.

For the year, the company raised its forecast for per-share adjusted earnings from continuing operations by two cents and now expects $3.86 to $4.

CVS's retail pharmacy business gained customers last year in the wake of a contract dispute between rival Walgreen Co.'s (>> Walgreen Company) and pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that has since been resolved.

A wave of major generic drugs introductions is having a mixed effect on the industry. Though the copycat drugs carry higher margins than branded products, they command lower prices, hurting sales revenue.

CVS Caremark reported a profit of $1.13 billion, or 90 cents a share, up from $1.1 billion, or 81 cents a share, a year earlier. Excluding debt-extinguishment losses, acquisition-related charges and other items, adjusted earnings from continuing operations were $1.14. Revenue increased 11% to $31.39 billion.

Analysts polled by Thomson Reuters most recently projected earnings of $1.10 on revenue of $31.13 billion.

Revenue in the larger pharmacy-services business climbed 17% to $18.6 billion, reflecting new client starts, higher prices and growth of its Medicare Part D program. Pharmacy network claims processed rose 6.5%.

On the retail side, revenue increased 5.1% to $16.3 billion. Same-store sales were up 4% from a year earlier, as pharmacy same-store sales also improved by 4%. Same-store sales in the front end of the store grew 3.9%.

Shares closed Tuesday at $51.72 and were inactive premarket.

Write to Tess Stynes at tess.stynes@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
08/26 CVS HEALTH : Fighting Opioid Abuse with Technology
08/26 CVS HEALTH : Talent Is Ageless
08/25 CVS HEALTH : Survey Reveals Two in Five Americans Make Multiple Trips to get Ent..
08/25 CVS HEALTH : and the CVS Health Foundation Announce $100K Donation In Support of..
08/24 CVS HEALTH : and Easterseals Celebrate Ten Years of Partnership to Support our N..
08/23 CVS HEALTH : Research Institute Study Shows Value in Tailoring Medication Adhere..
08/23 Report says Citizens' R.I. tax credits skyrocket from $3.4M to $11.9M in fisc..
08/22 CVS HEALTH : teams up with Roca to provide at-risk women with career training
08/18 CVS HEALTH : and the CVS Health Foundation Announce $100K Donation In Support of..
08/18 CVS HEALTH : Lipinski Announces Installation of Drop Box for Unwanted Prescripti..
More news
Sector news : Drug Retailers - NEC
08/22DJSINOPHARM GROUP : 1st Half Net Profit CNY2.53 Billion, Up 32% on Year
08/09DJPatient Survey Company Press Ganey to Sell Itself to Swedish Firm EQT
08/09DJValeant Posts a Loss and Says It Will Retool
08/02DJCARDINAL HEALTH : Warns of Quarterly Profit Decline
08/02DJCARDINAL HEALTH : Warns of Quarterly Profit Decline
More sector news : Drug Retailers - NEC
News from SeekingAlpha
08/25 Amazon v. Wal-Mart In Brewing Takeover Battle
08/22 Why I Didn't Buy Gilead, Apple Or 100 Others, Y'all - Part 3
08/21 MY PORTFOLIO UPDATE AND REVIEW OF 83 : Up 2 With Reynolds And Exelon, Down 1 Wit..
08/17 10 Dividend Growth Stocks For August 2016
08/16 SNIPPET ROUNDUP : Biogen Buy Rumours, CVS Cuts And Spark Gains On Shire's Loss
Advertisement
Financials ($)
Sales 2016 179 904 M
EBIT 2016 10 782 M
Net income 2016 5 700 M
Debt 2016 24 998 M
Yield 2016 1,75%
P/E ratio 2016 18,03
P/E ratio 2017 15,00
EV / Sales 2016 0,69x
EV / Sales 2017 0,63x
Capitalization 99 435 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 111 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-4.61%99 435
WALGREENS BOOTS ALLIAN..-6.77%85 925
EXPRESS SCRIPTS HOLDIN..-17.27%45 571
MCKESSON CORPORATION-7.32%41 256
CARDINAL HEALTH INC-11.11%25 280
AMERISOURCEBERGEN CORP..-17.32%18 413
More Results